|
|
|
|
Only 27%of antiepileptic drug level determinations had an appropriate indication,and half of these were not sampled correctly.Routine daily monitoring without pharmacological justification accounted for most of the inappropriate drug level determinations.Efforts to decrease inappropriate monitoring may result in substantial cost reductions without missing important clinical results. |
|